# Sciegen Pharmaceuticals Inc - Inspection Records Source: https://www.keypedia.com/companies/sciegen-pharmaceuticals-inc/814ff2a4-e264-431f-bffa-9932abda619d > Inspection records and compliance data for Sciegen Pharmaceuticals Inc in Hauppauge, New York. Access full analysis and detailed observations. --- ## Details - Name: Sciegen Pharmaceuticals Inc - FEI Number: 3008298016 - City: Hauppauge - State: New York - Country Name: United States - Address Line 1: 89 Arkay Dr - Zip Code: 11788 - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK ## Related Documents - [FDA Inspection 1297968 - Sciegen Pharmaceuticals Inc - 2025-12-19](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/d3faa575-0975-4a44-9f38-ff5d4d5c76a1) — source: FDA, date: December 19, 2025 - [FDA Inspection 1297968 - Sciegen Pharmaceuticals Inc - 2025-12-19](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/dbc62b1e-da3f-4e51-b99e-d9e5f6698380) — classification: No Action Indicated (NAI), source: FDA, date: December 19, 2025 - [FDA Inspection 1229682 - Sciegen Pharmaceuticals Inc - 2024-02-20](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/c0bb89dd-507e-46db-a766-fad3d39acd40) — classification: No Action Indicated (NAI), source: FDA, date: February 20, 2024 - [FDA Inspection 1204858 - Sciegen Pharmaceuticals Inc - 2023-04-21](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/78debf30-0ef4-42cc-be44-6bb8ef0669d0) — classification: Official Action Indicated (OAI), source: FDA, date: April 21, 2023 - [483 - Sciegen Pharmaceuticals Inc - 2023-04-17](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/e2f9042a-4ff1-46f0-bbb2-f2cb753419c1) — source: FDA, date: April 17, 2023 - [483 - Sciegen Pharmaceuticals Inc - 2022-09-02](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/500247d4-c1a2-41f6-9bee-15b0e37ef216) — source: FDA, date: September 2, 2022 - [FDA Inspection 1178870 - Sciegen Pharmaceuticals Inc - 2022-09-02](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/2cf09840-dbd9-4665-b3f8-2df1a91433da) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 2, 2022 - [483 - Sciegen Pharmaceuticals Inc - 2021-12-20](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/1634f312-1a9c-465b-9cc8-830b78799bbc) — source: FDA, date: December 20, 2021 - [FDA Inspection 1159297 - Sciegen Pharmaceuticals Inc - 2021-12-20](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/6531e5fc-0ab2-40b5-ae2a-c83d5ed9f6a0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 20, 2021 - [FDA Inspection 1093708 - Sciegen Pharmaceuticals Inc - 2019-06-21](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/6983c090-ecdf-4b54-a422-dce8d783eebd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 21, 2019 - [FDA Inspection 1052720 - Sciegen Pharmaceuticals Inc - 2018-04-20](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/a8d7e0f4-29f3-4f7b-b8bf-f8cf5f0314e1) — classification: No Action Indicated (NAI), source: FDA, date: April 20, 2018 - [FDA Inspection 1051153 - Sciegen Pharmaceuticals Inc - 2018-03-16](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/778bd4b5-2ed5-491c-aef0-8ce51043e54c) — classification: No Action Indicated (NAI), source: FDA, date: March 16, 2018 - [FDA Inspection 1047471 - Sciegen Pharmaceuticals Inc - 2018-03-14](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/2a1b157d-8466-4119-958b-ed67a7f76a83) — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2018 - [483 - Sciegen Pharmaceuticals Inc - 2015-01-09](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/5e31791b-c59c-42d6-8153-31d0bd380825) — source: FDA, date: January 9, 2015 - [483 - Sciegen Pharmaceuticals Inc - 2011-09-16](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/1d284827-ee38-4511-b570-a5c012157fbc) — source: FDA, date: September 16, 2011 ## Related Companies - [Sanofi S.r.l.](https://www.keypedia.com/companies/sanofi-srl/54ba861a-36eb-4486-a4ba-2a8194cdf7a5) - [KP Pharmaceutical Technology](https://www.keypedia.com/companies/kp-pharmaceutical-technology/acd7d203-2bd2-4702-a902-83c45f57890f) - [Patheon Puerto Rico, Inc.](https://www.keypedia.com/companies/patheon-puerto-rico-inc/e9addf1c-234e-45b2-a136-75152851936b) - [Unichem Laboratories Limited](https://www.keypedia.com/companies/unichem-laboratories-limited/2b8c7905-52a2-4b2e-a97e-0a1d5b2d88ea) - [Recipharm Pharmaservices Private Limited](https://www.keypedia.com/companies/recipharm-pharmaservices-private-limited/cb3eebaa-2270-4301-a4a2-3ce95d076cd6) - [United Therapeutics Corporation](https://www.keypedia.com/companies/united-therapeutics-corporation/5f83ecf2-e9e1-408a-9a1b-b381eac864a1) - [Macleods Pharmaceuticals Limited](https://www.keypedia.com/companies/macleods-pharmaceuticals-limited/cd51cd03-2afe-4dcd-93b4-20beee9d0521) - [C.P.M. Contract Pharma GmbH & Co. KG](https://www.keypedia.com/companies/cpm-contract-pharma-gmbh-co-kg/603d56c1-f951-4a2d-9098-cd2fc6ee54f6) - [Micro Labs Limited](https://www.keypedia.com/companies/micro-labs-limited/31ef3982-06b8-43c1-8e7e-585fb2dd02e7) - [TEVA Pharmaceuticals USA, Inc.](https://www.keypedia.com/companies/teva-pharmaceuticals-usa-inc/80ca25b0-727b-44e6-aedf-39bf4f30ef14) ## Related Officers - [Neil J. Bonzagni](https://www.keypedia.com/people/neil-j-bonzagni/67201e71-0bc0-45b8-b5f5-4c24d80b9325) - [Biotechnology Specialist at FDA](https://www.keypedia.com/people/robert-c-horan/81b78f43-200d-4eaa-a586-fe2101759ffd) - [Gam S Zamil, Investigator](https://www.keypedia.com/people/gam-s-zamil-investigator/5e54b8cd-7ac7-47b1-9120-c04046a63092) - [Vivin George, Investigator](https://www.keypedia.com/people/vivin-george-investigator/75670ca1-ec63-4dbd-a763-2c4aa31bac6a)